[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-346058-105":59,"doc-detail-346058-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","immunotherapy-for-cancer-current-advances-and-future-directions-review","Immunotherapy for Cancer: Current Advances and Future Directions - Review","","Immunotherapy represents a fundamental shift in the treatment of multiple cancers by using the patient’s immune system to precisely identify and destroy cancer cells. The review outlines key immunotherapy approaches, including immune checkpoint inhibitors, adoptive cell therapies, cancer vaccines, tumor microenvironment reprogramming, monoclonal antibodies, cytokine therapies, oncolytic virus therapy, and combination strategies. It also discusses clinical challenges and future directions toward personalized and combination regimens, AI support, and improved delivery systems.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/immunotherapy-for-cancer-current-advances-and-future-directions-review/346058/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/immunotherapy-for-cancer-current-advances-and-future-directions-review/346058.png","ImageObject",300,407,{"name":92,"@type":93},"Theodora","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-31","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":34},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"How does immunotherapy differ from conventional cancer therapies?","Question",{"text":112,"@type":113},"Immunotherapy leverages the patient’s immune system to identify and destroy cancer cells, unlike conventional therapies that do not directly mobilize immune recognition in the same way.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"What major immunotherapy approaches are covered in the review?",{"text":117,"@type":113},"The review covers immune checkpoint inhibitors, adoptive cell therapies, cancer vaccines, tumor microenvironment reprogramming, monoclonal antibodies, cytokine therapies, oncolytic virus therapy, and combination strategies.",{"name":119,"@type":110,"acceptedAnswer":120},"What challenges and future directions are emphasized?",{"text":121,"@type":113},"Despite clinical effectiveness, immunotherapies face limitations in implementation. Future directions focus on personalized and combination therapies, integrating AI, and strengthening delivery systems.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},346058,1790622906,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":34,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},687197207919,"https://ap-avatar.wpscdn.com/avatar/a000253d6f5f7c60be?x-image-process=image/resize,m_fixed,w_180,h_180&k=1779446848396160552","Review  \nImmunotherapy for Cancer: Current Advances and Future Directions  \nTanya Saxena 1,†, Shamsuz Zaman 1,†, Himanshu Dhanda 1, Sandeep Kumar Swain 1, Neetu Kushwaha 1, Manpreet Kaur 1, Raj Kamal 1, Sufian Zaheer 2, Pranay Tanwar 3, Neeraj Kumar 1, Fouzia Siraj 4, Bhavika Rishi 1, * and Aroonima Misra 1, *  \nAcademic Editor: Roberto Perris  \nReceived: 7 April 2026  \nRevised: 15 May 2026  \nAccepted: 20 May 2026  \nPublished: 13 August 2026  \nCopyright: © 2026 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license.  \n1 National Institute of Child Health Development Research, Indian Council of Medical Research, New Delhi 110029, India  \n2 Department of Pathology, Vardhman Mahavir Medical College and Safdarjung Hospital, New Delhi 110029, India  \n3 Laboratory Oncology Unit, Dr. B.R. Ambedkar Institute Rotary Cancer Hospital, AIIMS, New Delhi 110029, India  \n4 Centre for Cancer Pathology, Indian Council of Medical Research, New Delhi 110029, India  \n* [Correspondence: bhavikarishi.nip@icmr.gov.in](Correspondence: bhavikarishi.nip@icmr.gov.in) (B.R.); [misra.aroonima@icmr.gov.in](misra.aroonima@icmr.gov.in) (A.M.)† These authors contributed equally to this work.  \nAbstract  \nImmunotherapy delivers a fundamental shift in the treatment of multiple cancers, offering hope for patients with cancer. Unlike conventional therapies, it leverages the patient’s immune system to precisely identify and destroy cancer cells. The remarkable journey of immunotherapy’s has revolutionized oncology and paved the way for the development of modern immunotherapies. Several approaches are applied for immunotherapy, including immune checkpoint inhibitors, adoptive cell therapies, cancer vaccines, tumor microenvironment reprogramming, monoclonal antibodies, cytokine therapies, oncolytic virus therapy and combination strategies. Various immunotherapies are being used for different types of cancers like skin, lung, bladder, kidney, liver, breast and blood cancers. Despite providing an effective cancer treatment, immunotherapies face some challenges in their clinical implementation. To overcome these limitations, future directions emphasize the development of personalized and combination therapies, the incorporation of AI and a good delivery system. The main aim of this review is to give an overview of the journey of evolution, different approaches, limitations, advances and future development for immunotherapy in cancer treatment.  \nKeywords: immunotherapy; immune checkpoint inhibitors; adoptive cell therapies; cancer vaccines; tumor microenvironment reprogramming; monoclonal antibodies; cytokine therapies; oncolytic virus therapy  \n1. Introduction  \nCancer remains a prominent cause of death across the world. The estimations from the International Agency for Research on Cancer (IARC) reported that in 2022, there were 20 million new cancer cases and 9.7 million deaths [1] . There are numerous genetic and environmental factors responsible for the development of cancer. Significant advancements have been made in the understanding of causes, pathophysiology and treatment of cancer. Over the past few decades, immunotherapy has developed as an innovative treatment approach for multiple cancers. This review summarizes the different approaches for  \nimmunotherapy in cancer with a brief overview of the advances and future research associated with them.  \n1.1. Cancer and the Immune System: An Overview  \nThe immune system helps our body fight against infections and plays a crucial role in the regulation of cancer growth and metastasis. The available literature strongly suggests that the immune system detects and controls the development of the tumor through a process called immunosurveillance [2] . The progression of cancer is controlled by both innate and adaptive immune systems. The innate immunity does not involve the specific tumor ant","cbCaiq9OUEsBLinC","https://ap.wps.com/l/cbCaiq9OUEsBLinC","pdf",4167250,29,"English","# 1. Introduction\n## 1.1. Cancer and the Immune System: An Overview\n## 1.2. The Evolution of Cancer Treatment Approaches","[{\"question\":\"How does immunotherapy differ from conventional cancer therapies?\",\"answer\":\"Immunotherapy leverages the patient’s immune system to identify and destroy cancer cells, unlike conventional therapies that do not directly mobilize immune recognition in the same way.\"},{\"question\":\"What major immunotherapy approaches are covered in the review?\",\"answer\":\"The review covers immune checkpoint inhibitors, adoptive cell therapies, cancer vaccines, tumor microenvironment reprogramming, monoclonal antibodies, cytokine therapies, oncolytic virus therapy, and combination strategies.\"},{\"question\":\"What challenges and future directions are emphasized?\",\"answer\":\"Despite clinical effectiveness, immunotherapies face limitations in implementation. Future directions focus on personalized and combination therapies, integrating AI, and strengthening delivery systems.\"}]","Immunotherapy for Cancer: Current Advances and Future Directions - Review | PDF",1790059908,73,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/6b5bbaf7cee57e9ff7075451661a1054.webp",983,1390,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c5c2c14e2a1e4972a32922f7ccf1875e.webp",982,1388,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/4109b3170cca941a6f883dc239a6f81b.webp",981,1387,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/304f6ec961166794e78a95354ebca5ac.webp",980,1385]